IMPACT BIOMEDICAL INC. (IBO)
↓ Download CSV- Sector Manufacturing
- Incorporated NV
- Fiscal year ends Dec 31
In fiscal 2025, IMPACT BIOMEDICAL INC. reported revenue of $32.0K. The company ran a net loss, with a net margin of -36993.8%. It held $17.41M in total assets against $1.85M in total liabilities.
Key ratios (FY2025)
-13381.2%
Operating margin
-36993.8%
Net margin
-76.1%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $32.0K | — | — | $50.0K | — |
| Cost of Revenue | $424.0K | — | — | — | — |
| Operating Income | -$4.28M | -$28.75M | -$4.03M | -$3.40M | — |
| Net Income | -$11.84M | -$24.71M | -$4.34M | -$7.25M | — |
| EPS (Diluted) | $-0.38 | $-2.30 | $-0.07 | $-0.10 | — |
| Total Assets | $17.41M | $20.29M | $44.63M | $46.50M | — |
| Total Liabilities | $1.85M | $13.05M | $16.37M | $13.83M | — |
| Shareholders' Equity | $15.55M | $7.24M | $28.26M | $32.67M | $39.92M |
| Cash & Equivalents | $3.0K | $2.00M | $1.0K | $2.0K | — |
| Operating Cash Flow | -$1.89M | -$2.85M | -$2.85M | -$2.24M | — |
| Shares Outstanding | 104.62M | 11.50M | 10.00M | 70.50M | — |